Urinary Antiseptic Antispasmodic
Prescription商品名： Me NaPhos MB Hyo 1
About This Medication
Description Each tablet contains: Methenamine, USP ................................. 81.6 mg Monobasic Sodium Phosphate, USP ......... 40.8 mg Methylene Blue ....................................... 10.8 mg Hyoscyamine Sulfate ............................... 0.12 mg
有効成分
| 成分 | 含有量 |
|---|---|
| Hyoscyamine Sulfate Anhydrous | - |
| Methenamine | - |
| Methylene Blue Anhydrous | - |
| Sodium Phosphate, Monobasic, Monohydrate | - |
適応症と用法
用量と投与方法
Side Effects Overview
警告と注意事項
WARNINGS Do not exceed recommended dosage. If rapid pulse, dizziness, or blurring of vision occurs discontinue use immediately.
Frequently Asked Questions
INDICATION AND USAGE ME/NaPhos/MB/Hyo 1 Tablets is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
DOSAGE AND ADMINISTRATION Adults One tablet orally 4 times per day followed by liberal fluid intake. Older Children Dosage must be individualized by physician. Not recommended for use in children up to 6 years of age.
WARNINGS Do not exceed recommended dosage. If rapid pulse, dizziness, or blurring of vision occurs discontinue use immediately.
Urinary Antiseptic Antispasmodic is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Urinary Antiseptic Antispasmodic drug label (National Library of Medicine)
- • openFDA — Urinary Antiseptic Antispasmodic label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 1050325 (NLM Normalized Drug Names)
- • NDC Directory — Urinary Antiseptic Antispasmodic (FDA National Drug Code)
医療免責事項
このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。
疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。
データソース： DailyMed (NLM), openFDA, MFDS